Pharvaris Reconciled Depreciation from 2010 to 2024

PHVS Stock  USD 22.36  1.81  7.49%   
Pharvaris Reconciled Depreciation yearly trend continues to be comparatively stable with very little volatility. Reconciled Depreciation is likely to outpace its year average in 2024. From the period from 2010 to 2024, Pharvaris Reconciled Depreciation quarterly data regression had r-value of  0.76 and coefficient of variation of  185.85. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2010-12-31
Previous Quarter
237.7 K
Current Value
249.6 K
Quarterly Volatility
89.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pharvaris financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharvaris' main balance sheet or income statement drivers, such as Tax Provision of 634.5 K, Net Interest Income of 223.4 K or Depreciation And Amortization of 54.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.41. Pharvaris financial statements analysis is a perfect complement when working with Pharvaris Valuation or Volatility modules.
  
Check out the analysis of Pharvaris Correlation against competitors.

Latest Pharvaris' Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Pharvaris BV over the last few years. It is Pharvaris' Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharvaris' overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Pharvaris Reconciled Depreciation Regression Statistics

Arithmetic Mean48,370
Geometric Mean0.00
Coefficient Of Variation185.85
Mean Deviation69,882
Median0.00
Standard Deviation89,893
Sample Variance8.1B
Range249.6K
R-Value0.76
Mean Square Error3.7B
R-Squared0.58
Significance0
Slope15,253
Total Sum of Squares113.1B

Pharvaris Reconciled Depreciation History

2024249.6 K
2023237.7 K
2022152.9 K
202177.4 K
2020 7401.0
2019 549.0

About Pharvaris Financial Statements

Pharvaris shareholders use historical fundamental indicators, such as Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Although Pharvaris investors may analyze each financial statement separately, they are all interrelated. The changes in Pharvaris' assets and liabilities, for example, are also reflected in the revenues and expenses on on Pharvaris' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Reconciled Depreciation237.7 K249.6 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.